ADC Solution

In the field of tumor treatment, antibody-coupled drugs (ADC) can improve the efficacy and specificity of cancer treatment by combining monoclonal antibodies with potent cytotoxic drugs. The core idea is to use the targeting characteristics of antibodies to deliver cytotoxic drugs directly to cancer cells to achieve therapeutic effects. ADC drugs are complex and special, with serious toxicity, and there are many risks and challenges in the production process. Tofflon has rich experience in preparation of monoclonal antibody, drug-loaded coupling, purification and preparation production, and provides information solutions (equipment+engineering+consumables), especially in antibody production, disposable technology, coupling technology, purification technology, operation and preparation of toxic drugs, freeze-drying, etc., which can provide reliable process support and help you implement it from research and development to commercialization.

Tofflon Science and Technology Group Co., Ltd.

Purification Process
Cryopreservation Of The Original Solution
Auxiliary System
Preparation
Isolation System
Isolation System1
Isolation System2

Centrifugal

Membrane Filtration

Chromatographic Process

Parts

(M+E+C)&AI&

Relying on the understanding of regulations and processes, provide reliable end-to-end equipment and facilities from R&D to commercialization; Through planning and design, procurement management, engineering construction, system verification and other processes, integrated delivery of factories with specific functions; Provide core process consumables such as culture medium, filler, filter and disposable reaction bag to assist process optimization and solve the problem of stock solution production; Relying on information and intelligent time experience, we will provide forward-looking and professional digital planning to help enterprises transform digitally.